These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21666199)

  • 1. Impact of supplementary immunization activities in measles-endemic areas: a case study from Guangxi, China.
    Zhuo J; Geng W; Hoekstra EJ; Zhong G; Liang X; Zhang J
    J Infect Dis; 2011 Jul; 204 Suppl 1():S455-62. PubMed ID: 21666199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in measles control--Zambia, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):581-4. PubMed ID: 15959454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International measles incidence and immunization coverage.
    Hall R; Jolley D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S158-63. PubMed ID: 21666157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in global measles control, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in accelerated measles control in the People's Republic of China, 1991-2000.
    Lixia W; Guang Z; Lee LA; Zhiwei Y; Jingjin Y; Jun Z; Xiaofeng L; Chang X; Huqun B
    J Infect Dis; 2003 May; 187 Suppl 1():S252-7. PubMed ID: 12721922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in measles mortality reduction in Ethiopia, 2002-2009.
    Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward interruption of endemic measles transmission in Tunisia.
    Garbouj M; Slim A; Ghorbal MB; Khamassi S; Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S172-6. PubMed ID: 12721910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative use of surveillance data to harness political will to accelerate measles elimination: experience from Guangxi, China.
    Zhuo J; Hoekstra EJ; Zhong G; Liu W; Zheng Z; Zhang J
    J Infect Dis; 2011 Jul; 204 Suppl 1():S463-70. PubMed ID: 21666200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of a measles epidemic in Vietnam 2008-2010.
    Sniadack DH; Mendoza-Aldana J; Huyen DT; Van TT; Cuong NV; Olive JM; Toda K; Hien NT
    J Infect Dis; 2011 Jul; 204 Suppl 1():S476-82. PubMed ID: 21666203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in measles control--Nepal, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(39):1028-31. PubMed ID: 17914331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(12):374-8. PubMed ID: 21451448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward measles elimination in Bahrain--a Middle East country experience.
    Jawad JS; Al-Sayyad AS; Sataih F; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S299-304. PubMed ID: 21666177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
    J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(24):513-6. PubMed ID: 11432675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.